Role of B lymphocytes in atherosclerosis

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Heart attacks and stroke, underpinned by atherosclerosis, are the number one cause of deaths in our community. While statin reduces cholesterol, there is no treatment to reduce the inflammation initiated by cholesterol entry into blood vessel walls. Our studies are directed towards precise identification of subsets of an inflammatory cell (B lymphocyte) that promote or attenuate atherosclerosis.Therapeutic targeting of these subsets has potential to reduce the inflammation in atherosclerosis

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $624,960.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

B cells | atherosclerosis | inflammation | myocardial infarction | peripheral vascular disease | stroke